Most Recent
AMP to have ‘dialogue’ with class action lawyers, court hears
AMP appeared in court Friday to defend the first of five class actions filed on behalf of shareholders in the wake of damaging Royal Commission hearings into its conduct over advice fees.
Blockbuster loses appeal over franchisee’s unauthorised sale
Blockbuster has struck out in its challenge to a ruling that it could not recover a cent from a husband and wife franchisee after the pair sold the store's assets without consent and admitted to breaching the franchise agreement.
Telstra misled consumers with ‘Unlimited’ ad campaign, Optus says
Optus and Telstra squared off court on Friday over an allegedly misleading ad campaign for the second time in a week, this time over Telstra's 'Unlimited' ad campaign.
Viterra loses third bid for Cargill talks with Allens over Joe White sale
Viterra has failed in its third bid to access communications between Cargill Australia and its lawyers related to Cargill's $420 million purchase of malt producer Joe White Maltings from Viterra in 2013.
Dorevitch Pathology settles union’s Fair Work case over lockout
The union representing Dorevitch Pathology workers has settled a Fair Work case against the lab giant over a lockout notice the company sent to staff ahead of last year's planned strike over pay.
Slater & Gordon vies for AMP shareholders with ‘best deal’ yet
Not to be outdone by other class action firms vying to recruit AMP shareholders for a $2 billion class action, Slater & Gordon announced Friday it would offer investors "the most competitive funding package of all".
BHP faces possible Australian class action over Brazil mine disaster
Boutique law firm Phi Finney McDonald is investigating a potential shareholder class action against BHP Billiton over the fatal Samarco disaster in Brazil, which saw the market value of the mining giant plummet by $25 billion.
Shine joins AMP class action frenzy
Beleaguered financial institution AMP is facing yet another shareholder class action with Shine Lawyers joining three other law firms in what is shaping up to be a beauty pageant of class actions.
DLA Piper’s patent advice to Neurim not privileged, court hears
Two generic drug makers are fighting for access to confidential documents related to amendments by Neurim Pharmaceutical of patents covering its sleep drug Circadin, telling the Federal Court on Thursday privilege had been waived after a phone conversation between the company's founder and her lawyers from DLA Piper.
ASIC vows to use ‘every inch’ of power to go after corporate violators
ASIC's newly installed chief on Thursday slammed banks and other financial firms for their "trust deficit" and vowed to deploy "every inch of our powers and tools" to go after violators.